National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

recombinant human methionyl stem cell factor (ree-KOM-bih-nunt HYOO-mun meh-THY-oh-nil stem sel FAK-ter)

 A substance that causes blood stem cells (cells from which other types of cells develop) to change into different types of blood cells and increases the number and actions of these cells in the blood. It is being studied in the treatment of myelodysplasia. Recombinant human methionyl stem cell factor is a type of recombinant stem cell growth factor. Also called ancestim, r-metHuSCF, and Stemgen.



Previous Definitions:recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine, recombinant human interleukin-2, recombinant human interleukin-11
Next Definitions:recombinant tissue plasminogen activator, recombinant vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-TRICOM vaccine, reconstructive surgeon, reconstructive surgery

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov